In a strategic move aimed at enhancing the quality of medical research in Saudi Arabia, the Saudi Commission for Health Specialties has officially adopted a set of new and updated standards for inclusion in the "Clinical Research Practitioner" registry. This regulatory step aims to strengthen governance of the clinical research sector and ensure the competence of practitioners, and these regulations are scheduled to come into effect on September 9, 2025.
Strict academic and professional requirements
The updated standards aim to streamline the registration process through a rigorous screening of applicants to ensure the highest quality standards. The authority has imposed a fundamental requirement regarding academic qualifications: applicants must hold a recognized health qualification, at least a bachelor's degree, in one of the core health disciplines. These disciplines include medicine and surgery, pharmacy, nursing, or any other directly related health field, thus excluding those without expertise in this vital sector.
The authority did not limit itself to academic qualifications alone, but also made acceptance into the registry contingent upon a valid professional registration with the authority itself. This requirement ensures that the researcher is a certified and classified healthcare practitioner, thus enhancing the credibility of the research they will participate in. The conditions also included a fundamental clause concerning good conduct and character, considered an indispensable ethical pillar in the sensitive field of medical research.
Good Clinical Practice (GCP) certification and mandatory training
In line with aligning local standards with international protocols, the new regulations require applicants to obtain a Good Clinical Practice (GCP) certificate. The authority stipulated that this certificate must be valid and no more than three years old at the time of application, to ensure that practitioners are up-to-date on the latest global ethical and scientific practices in clinical trial management.
Furthermore, the standards introduced a new knowledge requirement mandating that applicants complete an online introductory course offered by the authority. This course focuses on familiarizing applicants with the registry's mechanisms and providing them with essential knowledge about the regulations and systems governing research and clinical trials within the Kingdom of Saudi Arabia, ensuring they operate within a clear legal framework.
The context of Vision 2030 and the importance of research governance
These amendments are particularly important when viewed within the context of the Kingdom's Vision 2030 and the Health Sector Transformation Program. The Kingdom is witnessing an unprecedented surge in clinical research, with previous Ministry of Health reports indicating a 51% increase in clinical research within a single year. This rapid growth necessitates a robust legislative and regulatory framework to ensure the safety of research participants and the reliability of the resulting data.
The establishment of a clinical research practitioner registry is not merely an administrative measure; it aims to position the Kingdom as a leading regional and international hub for medical research and drug development. The presence of qualified and accredited personnel, adhering to global standards, is a key attraction for international pharmaceutical companies and major research centers to conduct their clinical trials within the Kingdom, positively impacting the knowledge economy and the healthcare sector as a whole.
It is worth noting that the date of issuance of this regulatory document was October 24, 2024, and it is scheduled to undergo periodic review in 2026 to ensure that it keeps pace with the rapid scientific and regulatory developments in this field.
